Peritoneal Dialysis Market

The report "Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals) - Global Forecast to 2029", is projected to reach USD 12.70 Billion by 2029 from USD 9.58 Billion in 2024 at a CAGR of 5.8% during the forecast period.

Browse 241 market data Tables and 66 Figures spread through 252 Pages and in-depth TOC on "Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/peritoneal-dialysis-market-211750966.html

Patients and care providers have been preferring the peritoneal dialysis over hemodialysis since they enjoy its convenience, low infection rates, and excellent quality of life. In fact, it allows patients to administer dialysis at home, which is the supreme advantage in avoiding frequent visits to the hospital; hence, patients will enjoy more flexibility in their schedules for the delivery of the treatment. Such freedom to carry on with one's daily life-work and social, most importantly-is indeed highly welcomed by those who do not want to break up their work and social lives by being taken out of their houses by the need to visit a dialysis center a few times a week. Second, bloodstream infections have less been reported with PD than with hemodialysis, which accesses the bloodstream via a fistula or catheter, thereby increasing the risk of infection. PD, on the other hand utilizes natural filters by the peritoneal membrane in the abdomen which reduces considerably the risk of infection and all consequences stemming from it. Owing to these facts, both the patients and healthcare providers realize that PD has become a better and more patient-oriented dialysis modality.

This report categorizes the peritoneal dialysis market based on offering, modality, disease indication, end user and region.

“Peritoneal solution bags segment is accounted for the largest share of  peritoneal dialysis market”

The market share for solution bags of peritoneal dialysis solution was the largest because these are one-time, single-use consumables, they require continuous replenishment. In contrast to a dialysis machine being purchased only once, solution bags must be used every day, with demand always consistent and ongoing. Consequently, a constant revenue stream will be created for manufacturers and suppliers. Patients on peritoneal dialysis also need a minimum number of bags a day, which enlarges consumption. The reason why the solution bag segment remains on top in this market for peritoneal dialysis is that these bags are used and replaced at a high rate.

“Continuous Ambulatory Peritoneal Dialysis (CAPD) segment holds the largest market share of peritoneal dialysis market”

Continuous Ambulatory Peritoneal Dialysis (CAPD) has been associated with good patient outcomes, notably the longer preservation of residual kidney function compared to hemodialysis. CAPD's gentle and continuous nature helps reduce stress on kidneys, as such allowing patients to retain their ability at least for a long time. Moreover, the number of hospitalizations in CAPD patients is much smaller in comparison with hemodialysis patients, and this is mainly because of the home-based mode of treatment, as it reduces the threat of infections and complications possible at clinical levels. All these make CAPD patients heathier, with a higher quality of life and lower healthcare costs.

“End-stage renal disease segment accounted for the largest market share in the global peritoneal dialysis market and expected to grow at the highest CAGR during the forecast period”

In many countries around the world, governments and health organizations have been actively participating in efforts that promote increased patient awareness and access to dialysis treatments for end-stage renal disease (ESRD) patients. Such efforts range from public health campaigns and education programs to even subsidies promoting patients' knowledge of the types of dialysis available, including peritoneal dialysis. Many governments also extend healthcare coverage and offer additional financial incentives to improve access to dialysis among low-income populations. The above efforts, in particular, are crucial in developing countries that have weak medical structures. Such programs contribute to the growth of the world market for peritoneal dialysis, thereby enabling wider access to dialysis as well as increasing awareness.

“Home care setttings segment holds the largest market share in the global peritoneal dialysis market and expected to grow at the highest CAGR during the forecast period.”

Increased awareness of the advantages of home dialysis alternatives for patients as well as for healthcare professionals has been driving this evolution in the peritoneal dialysis market toward a home care setting. Patients have successfully gained comfort and flexibility associated with home-based treatments by gaining greater independence in managing their care. The home dialysis programme in the global dialysis market is on the rise due to the fact that healthcare providers are now more aware of healthcare being more cost-effective through home dialysis. It reduces the frequency of hospital visits, which consequently results in a decreased rate of complications. This has fueled a preference for home dialysis, which in turn has been accentuating the dominance of home dialysis and its adoption in the global dialysis market.

“Asia Pacific region is expected to exhibit the highest growth rate during the forecast period”

This is majorly driven by proactive healthcare reforms and policies initiated by governments in these nations for better access to dialysis treatments. Such measures concentrate on hospital infrastructures and making such basic dialysis facilities accessible to low-income groups. This includes increasing healthcare programs, then funding and subsidizing treatment costs, and raising public awareness of kidney disease and its management among governments as a strategy to address such significant disparities in access to healthcare. In that case, commitment towards improved healthcare delivery for underserved populations fosters a more inclusive environment to support peritoneal dialysis, which further drives the market growth in the region.

Key Market Players:

Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Baxter International Inc. (US), Fresenius Medical Care AG (Germany), Medtronic plc (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US), Utah Medical Products, Inc. (US), Terumo Corporation (Japan), Diaverum AB (Sweden), Medionics (Canada), Newsol Technologies (Canada), Apollo Dialysis Pvt Ltd (India), U.S. Renal Care, Inc. (US), Northwest Kidney Centers (US), Relavo (US), Mitra Industries Pvt Ltd (India), JMS Co., Ltd. (Japan), AMECATH (Egypt), Polymedicure (India), Huaren Pharmaceutical (China), AWAK Technologies (Singapore), Innovative Renal Care (US), Romsons (India), SSEM Mthembu Medical (Pty) Ltd (South Africa),  Renax Biomedical Technology Co., Ltd (China), and Advin Health Care (India).

Don’t miss out on business opportunities in Peritoneal Dialysis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]